Hormone Receptor-Positive and HER2-Positive Breast Cancer: A Medical Update
Follow
Featuring Sara Hurvitz, MD, FACP, learn about the use of targeted therapies for earlystage, hormone receptorpositive and HER2positive breast cancer, explore how these medicines reduce risk of recurrence and how they may be used before and after surgery.